1. Home
  2. PCRX vs CTO Comparison

PCRX vs CTO Comparison

Compare PCRX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo CTO Realty Growth Inc.

CTO

CTO Realty Growth Inc.

HOLD

Current Price

$19.15

Market Cap

599.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
CTO
Founded
2006
1902
Country
United States
United States
Employees
N/A
42
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
599.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
CTO
Price
$22.72
$19.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$37.20
$21.50
AVG Volume (30 Days)
579.3K
177.5K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
8.00%
EPS Growth
107.44
N/A
EPS
0.16
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
$7.63
Revenue Next Year
$8.54
$2.76
P/E Ratio
$139.00
N/A
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$15.07
52 Week High
$27.99
$20.25

Technical Indicators

Market Signals
Indicator
PCRX
CTO
Relative Strength Index (RSI) 50.23 57.54
Support Level $22.57 $17.14
Resistance Level $23.94 $19.82
Average True Range (ATR) 0.79 0.33
MACD -0.06 0.05
Stochastic Oscillator 53.31 91.54

Price Performance

Historical Comparison
PCRX
CTO

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About CTO CTO Realty Growth Inc.

CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.

Share on Social Networks: